Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sachin Sharma, Karan Wadhwa, Manjusha Choudhary & Vikas Budhwar. (2022) Ethnopharmacological perspectives of glucokinase activators in the treatment of diabetes mellitus. Natural Product Research 36:11, pages 2962-2976.
Read now
Read now
Yuqing Zhao, Lijun Xie, Ning Ou, Jie Wu, Hongwen Zhang, Sufeng Zhou, Yun Liu, Juan Chen, Lu Wang, Libin Wang, Jingjing Wang & Feng Shao. (2021) Tolerability, safety, pharmacokinetics and pharmacodynamics of SHR0534, a potent G protein-coupled receptor 40 (GPR40) agonist, at single- and multiple-ascending oral doses in healthy Chinese subjects. Xenobiotica 51:3, pages 297-306.
Read now
Read now
Tafere Mulaw Belete. (2020) A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus. Journal of Experimental Pharmacology 12, pages 1-15.
Read now
Read now
Aoife Egan & Adrian Vella. (2019) TTP399: an investigational liver-selective glucokinase (GK) activator as a potential treatment for type 2 diabetes. Expert Opinion on Investigational Drugs 28:9, pages 741-747.
Read now
Read now
André J. Scheen, Nicolas Paquot & Pierre J. Lefèbvre. (2017) Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes. Expert Opinion on Investigational Drugs 26:12, pages 1373-1389.
Read now
Read now
Articles from other publishers (26)
Darya A. Pon’kina, Sergey O. Kuranov, Mariya K. Marenina, Yulia V. Meshkova, Nataliya A. Zhukova, Mikhail V. Khvostov, Olga A. Luzina, Tatiana G. Tolstikova & Nariman F. Salakhutdinov. (2023) Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies. Pharmaceutics 15:6, pages 1670.
Crossref
Crossref
Alexandra Chirila, Mary E Nguyen, Jill Tinmouth & Ilana J Halperin. (2023) Preparing for Colonoscopy in People with Diabetes: A Review with Suggestions for Clinical Practice. Journal of the Canadian Association of Gastroenterology 6:1, pages 26-36.
Crossref
Crossref
Xin Zhao, Lijiao Deng, Lele Ren, Huanhuan Yang, Bin Wang, Xiaochan Zhu, Xiaoli Zhang, Chao Guo, Yi Zhang & Yunfeng Liu. (2023) VPAC2 receptor mediates VIP-potentiated insulin secretion via ion channels in rat pancreatic β cells. Experimental Cell Research 423:2, pages 113471.
Crossref
Crossref
Jun Nagamine. (2023) Pharmacological profile and clinical efficacy of imeglimin hydrochloride (TWYMEEG<sup>®</sup>Tablets), the orally drug for type 2 diabetes mellitus with the first dual mode of action in the world膵作用と膵外作用の2つの血糖降下作用をあわせもつ世界初の経口2型糖尿病治療薬イメグリミン塩酸塩（ツイミーグ<sup>®</sup>錠）の薬理学的特性と臨床効果. Folia Pharmacologica Japonica 158:2, pages 193-202.
Crossref
Crossref
Pierre Theurey, Carole Thang, Valdis Pirags, Andrea Mari, Giovanni Pacini, Sébastien Bolze, Sophie Hallakou‐Bozec & Pascale Fouqueray. (2022) Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity. Endocrinology, Diabetes & Metabolism 5:6.
Crossref
Crossref
Prateek Sharma, Sukhbir Singh, Neelam Sharma, Deepak Singla, Kumar Guarve & Ajmer Singh Grewal. (2022) Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators. Journal of Diabetes & Metabolic Disorders 21:1, pages 1129-1137.
Crossref
Crossref
Sevgican Demir, Peter P. Nawroth, Stephan Herzig & Bilgen Ekim Üstünel. (2021) Emerging Targets in Type 2 Diabetes and Diabetic Complications. Advanced Science 8:18, pages 2100275.
Crossref
Crossref
Linong Ji, Ying Du, Min Xu, Xiangjun Zhou, Zhaohui Mo, Jianhua Ma, Jiarui Li, Yufeng Li, Jingna Lin, Yanjun Wang, Jing Yang, Weihong Song, Hui Jin, Shuguang Pang, Hui Liu, Ping Li, Jie Liu, Minxiu Yao, Wenhui Li, Xiaohong Jiang, Feixia Shen, Houfa Geng, Haifeng Zhou, Jianmin Ran, Minxiang Lei, Yinghong Du, Shandong Ye, Qingbo Guan, Wenshan Lv, Huiwen Tan, Tao Chen, Jinkui Yang, Guijun Qin, Shiyun Li & Lei Chen. (2021) Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study. Diabetologia 64:5, pages 1066-1078.
Crossref
Crossref
Björn Runesson, Yang Xu, Abdul R. Qureshi, Bengt Lindholm, Peter Barany, Carl G. Elinder & Juan J. Carrero. (2020)
Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm
Creatinine
Measurements (
SCREAM
) project
. Diabetes, Obesity and Metabolism 22:8, pages 1425-1435.
Crossref
Crossref
Abdul Hameed, Sayed Ali Raza, M. Israr Khan, Janaki Baral, Achyut Adhikari, Mohammad Nur-e-Alam, Sarfaraz Ahmed, Adnan J. Al-Rehaily, Sajda Ashraf, Zaheer Ul-Haq & Rahman M. Hafizur. (2019) Tambulin from Zanthoxylum armatum acutely potentiates the glucose-induced insulin secretion via KATP-independent Ca2+-dependent amplifying pathway. Biomedicine & Pharmacotherapy 120, pages 109348.
Crossref
Crossref
Bashir Usman, Neha Sharma, Saurabh Satija, Meenu Mehta, Manish Vyas, Gopal L. Khatik, Navneet Khurana, Philip M. Hansbro, Kylie Williams & Kamal Dua. (2019) Recent Developments in Alpha-Glucosidase Inhibitors for Management of Type-2 Diabetes: An Update. Current Pharmaceutical Design 25:23, pages 2510-2525.
Crossref
Crossref
Meng Li, Yanqi Dang, Qiong Li, Wenjun Zhou, Jianping Zuo, Zemin Yao, Li Zhang & Guang Ji. (2019) Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice. Scientific Reports 9:1.
Crossref
Crossref
Aman Chandra Kaushik, Ajay Kumar, Ashfaq Ur Rehman, Muhammad Junaid, Abbas Khan, Shiv Bharadwaj, Shakti Sahi & Dong-Qing Wei. (2018) Deciphering G-Protein-Coupled Receptor 119 Agonists as Promising Strategy against Type 2 Diabetes Using Systems Biology Approach. ACS Omega 3:12, pages 18214-18226.
Crossref
Crossref
Abdul Hameed, Sajda Ashraf, M. Israr Khan, Rahman M. Hafizur & Zaheer Ul-Haq. (2018) Protein kinase A-dependent insulinotropic effect of selected flavonoids. International Journal of Biological Macromolecules 119, pages 149-156.
Crossref
Crossref
Tomoaki Koshizawa, Toshiharu Morimoto, Gen Watanabe, Tomoaki Fukuda, Nao Yamasaki, Sumihiko Hagita, Yoshikazu Sawada, Ayumu Okuda, Kimiyuki Shibuya & Tadaaki Ohgiya. (2018) Discovery of novel spiro[chromane-2,4′-piperidine] derivatives as potent and orally bioavailable G-protein-coupled receptor 119 agonists. Bioorganic & Medicinal Chemistry Letters 28:19, pages 3236-3241.
Crossref
Crossref
Dalong Zhu, Shenglian Gan, Yu Liu, Jianhua Ma, Xiaolin Dong, Weihong Song, Jiao'e Zeng, Guixia Wang, Wenjuan Zhao, Qiu Zhang, Yukun Li, Hui Fang, Xiaofeng Lv, Yongquan Shi, Haoming Tian, Linong Ji, Xin Gao, Lihui Zhang, Yuqian Bao, Minxiang Lei, Ling Li, Longyi Zeng, Xiaoying Li, Xinghua Hou, Yu Zhao, Tianxin Hu, Xiaoyun Ge, Guiyu Zhao, Yongguo Li, Yi Zhang & Li Chen. (2018) Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study. The Lancet Diabetes & Endocrinology 6:8, pages 627-636.
Crossref
Crossref
Ainhoa NietoVirneliz Fernández-VegaTimothy P. SpicerEmmanuel SturchlerPramisha AdhikariNicole KennedySean MandatPeter ChaseLouis ScampaviaThomas BannisterPeter HodderPatricia H. McDonald. (2018) Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119. ASSAY and Drug Development Technologies 16:5, pages 278-288.
Crossref
Crossref
A.J. Scheen. (2018) Perspectives dans le traitement pharmacologique du diabète de type 2 pour les 10 prochaines années. Médecine des Maladies Métaboliques 12:2, pages 174-181.
Crossref
Crossref
Jin Won Yang, Hyo Seon Kim, Yong‐Won Choi, Young‐Mi Kim & Keon Wook Kang. (2017)
Therapeutic application of
GPR119
ligands in metabolic disorders
. Diabetes, Obesity and Metabolism 20:2, pages 257-269.
Crossref
Crossref
Silvano Piovan, Audrei Pavanello, Giuliana Maria Ledesma Peixoto, Camila Cristina Ianoni Matiusso, Ana Maria Praxedes de Moraes, Isabela Peixoto Martins, Ananda Malta, Kesia Palma-Rigo, Claudinéia Conationi da Silva Franco, Paula Gimenez Milani, Antonio Sérgio Dacome, Silvio Claudio da Costa, Paulo Cezar de Freitas Mathias & Cecília Edna Mareze-Costa. (2018) Stevia Nonsweetener Fraction Displays an Insulinotropic Effect Involving Neurotransmission in Pancreatic Islets. International Journal of Endocrinology 2018, pages 1-7.
Crossref
Crossref
Prosenjit Mondal, Amit Prasad & Khyati Girdhar. (2017) Interventions to improve β-cell mass and function. Annales d'Endocrinologie 78:5, pages 469-477.
Crossref
Crossref
Graeme Milligan, Elisa Alvarez-Curto, Brian D. Hudson, Rudi Prihandoko & Andrew B. Tobin. (2017) FFA4/GPR120: Pharmacology and Therapeutic Opportunities. Trends in Pharmacological Sciences 38:9, pages 809-821.
Crossref
Crossref
Jean-Claude Henquin. (2017) Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas. Biochimie.
Crossref
Crossref
Satish K. GargDominique GiordanoTyler GalloViral N. Shah. (2017) New Medications for the Treatment of Diabetes. Diabetes Technology & Therapeutics 19:S1, pages S-128-S-140.
Crossref
Crossref
Kiyomu Fujii, Yi Luo, Rina Fujiwara-Tani, Shingo Kishi, Song He, Shuyun Yang, Takamitsu Sasaki, Hitoshi Ohmori & Hiroki Kuniyasu. (2017) Pro-metastatic intracellular signaling of the elaidic trans fatty acid. International Journal of Oncology 50:1, pages 85-92.
Crossref
Crossref
Cheng Chen, He Li & Ya-Qiu Long. (2016) GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space. Bioorganic & Medicinal Chemistry Letters 26:23, pages 5603-5612.
Crossref
Crossref